VIP
Preisspanne: 325,00 $ bis 600,00 $
-
Liefergarantie Kostenloser Nachversand, falls die Lieferung nicht ankommt
-
Reinheit ≥ 99 % Direkt vom Hersteller
-
Unabhängige Echtheitszertifikate COAs für dieses Produkt anzeigen →
-
Garantie auf Gutschriften Senden Sie uns ein beliebiges COA-Ergebnis und erhalten Sie eine Gutschrift
Mengenrabatte
Preis pro Packung (10 Ampullen). Der Rabatt gilt nur für dieses Präparat – keine Kombination mit anderen Produkten.
| Anzahl | Preis | Ersparnisse |
|---|---|---|
| 1 Packung | $325 | - |
| 2 Packungen | $276 | 15 % Rabatt |
| 3 Packungen | $235 | 28 % Rabatt |
| 5 Packungen | $211 | 35 % Rabatt |
| 10 Packungen | $190 | 42 % Rabatt |
| 25 Packungen | $171 | 47 % Rabatt |
| Anzahl | Preis | Ersparnisse |
|---|---|---|
| 1 Packung | $600 | - |
| 2 Packungen | $510 | 15 % Rabatt |
| 3 Packungen | $433 | 28 % Rabatt |
| 5 Packungen | $390 | 35 % Rabatt |
| 10 Packungen | $351 | 42 % Rabatt |
| 25 Packungen | $316 | 47 % Rabatt |
VIP — Vasoactive Intestinal Peptide Research Compound
VIP (Vasoactive Intestinal Peptide) is a 28-amino-acid neuropeptide first isolated from porcine intestine in 1970 by Said and Mutt. It is widely distributed through the central nervous system, gastrointestinal tract, immune cells, and vasculature – which is why it has been studied across neuroimmune, vasodilatory, and anti-inflammatory research axes. In the peptide-research toolkit, VIP is the reference neuropeptide for VPAC1/VPAC2 receptor characterization and for studies of Th1/Th2 cytokine balance.
Why VIP’s Multi-Receptor Profile Matters
VIP binds two G-protein-coupled receptors – VPAC1 and VPAC2 – that are expressed on different tissues. VPAC1 is concentrated on T cells, macrophages, and the intestinal epithelium; VPAC2 is concentrated on smooth muscle and the suprachiasmatic nucleus. That distribution is why a single peptide produces both immune-modulatory and vasodilatory signaling, and why VIP is cited across such a wide range of published research rather than sitting in one category.
| Studiengang | Was es im Klartext bedeutet |
|---|---|
| VPAC1 receptor (immune cells) | Modulates T-cell and macrophage cytokine release |
| VPAC2 receptor (smooth muscle) | Vasodilation and smooth-muscle relaxation |
| Zytokin-Balance | Shifts Th1/Th2 ratio toward a less pro-inflammatory profile |
| Circadian signaling (SCN) | VPAC2 in the suprachiasmatic nucleus supports circadian rhythm synchronization |
Forschungsanwendungen
VIP is used in studies examining:
- Anti-inflammatory signaling and Th1/Th2 cytokine balance
- VPAC1 and VPAC2 receptor characterization
- Vasodilation and smooth-muscle relaxation models
- Experimental arthritis and autoimmune-inflammation research
- Circadian signaling via suprachiasmatic nucleus endpoints
- CIRS (chronic inflammatory response syndrome) research literature
Technische Daten
| Format | Gefriergetrocknetes Pulver |
| Reinheit | ≥99% |
| Aliasnamen | Vasoactive Intestinal Peptide, Vasoactive Intestinal Polypeptide, VIP(1-28) |
| Verfügbare Größen | 5 mg · 10 mg |
| Lagerung | 2–8 °C ungeöffnet; mindestens 12 Monate haltbar |
| Verwendung | Nur für Forschungszwecke – nicht zur Anwendung am Menschen |
Rekonstitution
VIP arrives as a freeze-dried powder and is reconstituted with bacteriostatic water:
Gesamtmenge in mg im Fläschchen ÷ hinzugefügte Wassermenge in ml = mg pro ml
Beispiel: Eine 5-mg-Ampulle + 2 ml bakteriostatisches Wasser = 2,5 mg pro ml. Eine 10-mg-Ampulle + 2 ml = 5 mg pro ml.
Nach der Zubereitung bei 2–8 °C lagern und innerhalb von 28–30 Tagen verbrauchen.
Anmerkungen zum Protokoll
The following values are reference points extracted from published VIP research – not instructions. Because VIP has a short functional half-life (~2 minutes in circulation), the intranasal route is the most commonly documented research format in the published literature.
- Dose range reported in the literature: 50-200mcg per administration in published intranasal protocols
- Administration frequency in published studies: Typically 1-4x daily depending on endpoint
- Study durations reported: 4-12 weeks for inflammation and cytokine-balance endpoints
Common Questions About VIP Research
What is VIP peptide used for in research?
It is most commonly studied as a neuroimmune modulator. Published work covers anti-inflammatory signaling, Th1/Th2 cytokine balance, vasodilation, experimental arthritis models, and circadian signaling. It does not sit in a single category – VIP is cited across immune, vascular, and neuroscience literature.
What does VIP do in research models?
It binds two G-protein-coupled receptors (VPAC1 and VPAC2). VPAC1 activation modulates T-cell and macrophage cytokine release; VPAC2 activation produces smooth-muscle relaxation and vasodilation. The downstream effects cited in the literature include reduced pro-inflammatory cytokine output, vasodilation, and Th1/Th2 ratio shifts.
What is the difference between VIP and PACAP?
PACAP (pituitary adenylate cyclase-activating peptide) is VIP’s closest structural relative and shares the VPAC1 and VPAC2 receptors. PACAP also binds a third receptor (PAC1) with higher affinity than VIP. The two peptides are often studied together in neuroimmune research.
Is VIP FDA approved?
No. Vasoactive Intestinal Peptide is not FDA approved for any use. It is studied as a research compound only. Every vial WWP ships is labeled and sold strictly for laboratory and research use only.
How is VIP stored?
Ungeöffnete Fläschchen werden bei 2–8 °C gelagert und sind mindestens 12 Monate haltbar. Nach der Rekonstitution mit bakteriostatischem Wasser wird die Lösung bei 2–8 °C aufbewahrt und innerhalb von 28–30 Tagen verbraucht.
Reinheitsgarantie
Jede Charge weist eine Reinheit von ≥99 % auf. Senden Sie uns ein Analysezertifikat einer unabhängigen Prüfstelle, und wir stellen Ihnen unabhängig vom Ergebnis eine Gutschrift aus.




